These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 8135184)
1. Molecular genetic, cytogenetic, and immunophenotypic analyses in Castleman's disease of the plasma cell type. Ohyashiki JH; Ohyashiki K; Kawakubo K; Serizawa H; Abe K; Mikata A; Toyama K Am J Clin Pathol; 1994 Mar; 101(3):290-5. PubMed ID: 8135184 [TBL] [Abstract][Full Text] [Related]
2. An immunohistological and genotypic study of the plasma cell form of Castleman's disease. Hall PA; Donaghy M; Cotter FE; Stansfeld AG; Levison DA Histopathology; 1989 Apr; 14(4):333-46; discussion 429-32. PubMed ID: 2737612 [TBL] [Abstract][Full Text] [Related]
3. Diagnosis of Castleman's disease by identification of an immunophenotypically aberrant population of mantle zone B lymphocytes in paraffin-embedded lymph node biopsies. Menke DM; Tiemann M; Camoriano JK; Chang SF; Madan A; Chow M; Habermann TM; Parwaresch R Am J Clin Pathol; 1996 Mar; 105(3):268-76. PubMed ID: 8602606 [TBL] [Abstract][Full Text] [Related]
4. Lack of cytogenetic abnormalities in Castleman's disease. Menke DM; DeWald GW South Med J; 2001 May; 94(5):472-4. PubMed ID: 11372793 [TBL] [Abstract][Full Text] [Related]
5. Increased expression of vascular endothelial growth factor (VEGF) in Castleman's disease: proposed pathomechanism of vascular proliferation in the affected lymph node. Nishi J; Maruyama I Leuk Lymphoma; 2000 Jul; 38(3-4):387-94. PubMed ID: 10830746 [TBL] [Abstract][Full Text] [Related]
6. Primary marginal zone B-cell lymphoma of the lymph node resembling plasmacytoma arising from a plasma cell variant of Castleman's disease. A clinicopathological and immunohistochemical study of seven patients. Kojima M; Nakamura S; Motoori T; Shimano S; Murayama K; Tamaki Y; Shimizu K; Oyama T; Sugihara S; Sakata N; Masawa N APMIS; 2002 Dec; 110(12):875-80. PubMed ID: 12645666 [TBL] [Abstract][Full Text] [Related]
7. Systemic IgG4-related lymphadenopathy: a clinical and pathologic comparison to multicentric Castleman's disease. Sato Y; Kojima M; Takata K; Morito T; Asaoku H; Takeuchi T; Mizobuchi K; Fujihara M; Kuraoka K; Nakai T; Ichimura K; Tanaka T; Tamura M; Nishikawa Y; Yoshino T Mod Pathol; 2009 Apr; 22(4):589-99. PubMed ID: 19270642 [TBL] [Abstract][Full Text] [Related]
8. Monoclonality and polyclonality of plasma cells in Castleman's disease of the plasma cell variant. Radaszkiewicz T; Hansmann ML; Lennert K Histopathology; 1989 Jan; 14(1):11-24. PubMed ID: 2925176 [TBL] [Abstract][Full Text] [Related]
9. Hyaline vascular Castleman's disease with HMGIC rearrangement in follicular dendritic cells: molecular evidence of mesenchymal tumorigenesis. Cokelaere K; Debiec-Rychter M; De Wolf-Peeters C; Hagemeijer A; Sciot R Am J Surg Pathol; 2002 May; 26(5):662-9. PubMed ID: 11979097 [TBL] [Abstract][Full Text] [Related]
10. Clonal rearrangement for immunoglobulin and T-cell receptor genes in systemic Castleman's disease. Association with Epstein-Barr virus. Hanson CA; Frizzera G; Patton DF; Peterson BA; McClain KL; Gajl-Peczalska KJ; Kersey JH Am J Pathol; 1988 Apr; 131(1):84-91. PubMed ID: 2833104 [TBL] [Abstract][Full Text] [Related]
12. Multicentric Castleman's disease in association with a solitary plasmacytoma: a case report. Gould SJ; Diss T; Isaacson PG Histopathology; 1990 Aug; 17(2):135-40. PubMed ID: 2227838 [TBL] [Abstract][Full Text] [Related]
13. Castleman's disease: a study of a rare lymphoproliferative disorder in a university hospital. Al-Amri AM; Abdul-Rahman IS; Ghallab KQ Gulf J Oncolog; 2010 Jan; (7):25-36. PubMed ID: 20164006 [TBL] [Abstract][Full Text] [Related]
15. Inactivation of the IL-6 gene prevents development of multicentric Castleman's disease in C/EBP beta-deficient mice. Screpanti I; Musiani P; Bellavia D; Cappelletti M; Aiello FB; Maroder M; Frati L; Modesti A; Gulino A; Poli V J Exp Med; 1996 Oct; 184(4):1561-6. PubMed ID: 8879230 [TBL] [Abstract][Full Text] [Related]
17. [Angiofollicular lymphatic hyperplasia with plasmacytoma and polyneuropathy: a case report with immunohistochemical study]. Dworák O; Tschubel K; Zhou H; Meybehm M Klin Wochenschr; 1988 Jul; 66(13):591-5. PubMed ID: 3210655 [TBL] [Abstract][Full Text] [Related]
18. Angiofollicular lymph node hyperplasia (Castleman's disease) in an adolescent female. Clinical and immunologic findings. Massey GV; Kornstein MJ; Wahl D; Huang XL; McCrady CW; Carchman RA Cancer; 1991 Sep; 68(6):1365-72. PubMed ID: 1873789 [TBL] [Abstract][Full Text] [Related]
19. Pathohistological and immunohistochemical studies on Castleman's disease of the lymph node. Nagai K; Sato I; Shimoyama N Virchows Arch A Pathol Anat Histopathol; 1986; 409(2):287-97. PubMed ID: 3087057 [TBL] [Abstract][Full Text] [Related]
20. "Plasmacytoid T cells" in Castleman's disease. Immunohistologic phenotype. Harris NL; Bhan AK Am J Surg Pathol; 1987 Feb; 11(2):109-13. PubMed ID: 3544885 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]